Catalyst Wire Dossier Catalyst Wire Dossier

Pyrukynd

mitapivat · Agios Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Pyrukynd, covering 2025-11-18 to 2026-08-13. Get the full timeline:

Most recent: EMA Authorised: Pyrukynd (mitapivat sulfate) — Agios Netherlands B.V.

See pricing